Literature DB >> 9099942

90K (Mac-2 BP) in human milk.

N D'Ostilio1, G Sabatino, C Natoli, A Ullrich, S Iacobelli.   

Abstract

Human 90K, also known as Mac-2 binding protein (Mac-2 BP), is a secreted glycoprotein which is widely expressed, binds to the human macrophage-associated lectin Mac-2, and may have a role in host defence. We have measured the concentrations of 90K in human breast milk from eight healthy mothers delivering mature healthy infants after full-term pregnancy using a specific immunoenzymatic assay. Maximal 90K concentrations were observed on days 2-3 post-partum, and ranged from 13.4 to 79.2 microg/ml. The concentrations of 90K in the milk had no correlation with those in the maternal blood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9099942      PMCID: PMC2200461          DOI: 10.1046/j.1365-2249.1996.40745.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura.

Authors:  P Pelliccia; C Natoli; M T Petitti; A Verrotti; F Chiarelli; S Iacobelli
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children.

Authors:  B Gröschel; J J Braner; M Funk; R Linde; H W Doerr; J Cinatl; S Iacobelli
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections.

Authors:  B Fornarini; S Iacobelli; N Tinari; C Natoli; M De Martino; G Sabatino
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family.

Authors:  B Silvestri; F Calderazzo; V Coppola; A Rosato; S Iacobelli; C Natoli; A Ullrich; I Sures; M Azam; C Brakebush; L Chieco-Bianchi; A Amadori
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

5.  Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.

Authors:  Michael J V White; David Roife; Richard H Gomer
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

Review 6.  90K (Mac-2 BP) and galectins in tumor progression and metastasis.

Authors:  Antonino Grassadonia; Nicola Tinari; Ida Iurisci; Enza Piccolo; Alba Cumashi; Pasquale Innominato; Maurizia D'Egidio; Clara Natoli; Mauro Piantelli; Stefano Iacobelli
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

7.  Human milk galectin-3 binding protein and breast-feeding-associated HIV transmission.

Authors:  Christina S Chan; Hae-Young Kim; Chloe Autran; Jae H Kim; Moses Sinkala; Chipepo Kankasa; Mwiya Mwiya; Donald M Thea; Grace M Aldrovandi; Louise Kuhn; Lars Bode
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

8.  90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.

Authors:  Veronika Lodermeyer; Kristina Suhr; Nicola Schrott; Christian Kolbe; Christina M Stürzel; Daniela Krnavek; Jan Münch; Christian Dietz; Tanja Waldmann; Frank Kirchhoff; Christine Goffinet
Journal:  Retrovirology       Date:  2013-10-24       Impact factor: 4.602

9.  Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.

Authors:  Emina Emilia Torlakovic; Vicki Keeler; Chang Wang; Hyun J Lim; Leslie Ann Lining; Suzanne Laferté
Journal:  BMC Cancer       Date:  2009-07-24       Impact factor: 4.430

10.  High DMBT1 concentrations in breast milk correlate with increased risk of infection in preterm and term neonates.

Authors:  Sebastian Ronellenfitsch; Christel Weiß; David Frommhold; Lutz Koch; Jan Mollenhauer; Johannes Poeschl; Hanna Müller
Journal:  BMC Pediatr       Date:  2012-10-03       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.